Reduction of Platinum (IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor‐Targeted Therapeutically Enhanced …

G Liang, T Sadhukhan, S Banerjee… - Angewandte Chemie …, 2023 - Wiley Online Library
The development of PtIV prodrugs that are reduced into the therapeutically active PtII
species within the tumor microenvironment has received much research interest. In order to …
被引用次数：23 相关文章

Reduction of Platinum (IV) Prodrug Hemoglobin Nanoparticles with Deeply-Penetrating Ultrasound Radiation for Tumor-Targeted Therapeutically Enhanced …

G Liang, T Sadhukhan, S Banerjee, D Tang… - … (International ed. in …, 2023 - europepmc.org
The development of PtIV prodrugs that are reduced into the therapeutically active PtII
species within the tumor microenvironment has received much research interest. In order to …

Reduction of Platinum (IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor-Targeted Therapeutically Enhanced …

G Liang, T Sadhukhan, S Banerjee… - … (International ed. in …, 2023 - pubmed.ncbi.nlm.nih.gov
The development of Pt IV prodrugs that are reduced into the therapeutically active Pt II
species within the tumor microenvironment has received much research interest. In order to …